Efmody Den europeiske union - norsk - EMA (European Medicines Agency)

efmody

diurnal europe b.v. - hydrokortison - adrenal hyperplasia, congenital - kortikosteroider for systemisk bruk - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.

Leponex 100 mg Norge - norsk - Statens legemiddelverk

leponex 100 mg

viatris healthcare ltd. - klozapin - tablett - 100 mg

Leponex 25 mg Norge - norsk - Statens legemiddelverk

leponex 25 mg

viatris healthcare ltd. - klozapin - tablett - 25 mg

Subutex 8 mg Norge - norsk - Statens legemiddelverk

subutex 8 mg

indivior europe limited - buprenorfinhydroklorid - sublingvaltablett - 8 mg

Subutex 2 mg Norge - norsk - Statens legemiddelverk

subutex 2 mg

indivior europe limited - buprenorfinhydroklorid - sublingvaltablett - 2 mg

Sugammadex Adroiq Den europeiske union - norsk - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Norfol 10 mg/ ml Norge - norsk - Statens legemiddelverk

norfol 10 mg/ ml

norbrook laboratories ltd - propofol - injeksjonsvæske, emulsjon - 10 mg/ ml

Tecartus Den europeiske union - norsk - EMA (European Medicines Agency)

tecartus

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Teveten Comp 600 mg / 12.5 mg Norge - norsk - Statens legemiddelverk

teveten comp 600 mg / 12.5 mg

viatris healthcare ltd. - eprosartanmesilat / hydroklortiazid - tablett, filmdrasjert - 600 mg / 12.5 mg

Hypotron 5 mg Norge - norsk - Statens legemiddelverk

hypotron 5 mg

brancaster pharma ireland ltd. - midodrinhydroklorid - tablett - 5 mg